A triad of endocarditis, endophthalmitis, and meningitis

• Autorzy: Aušra Kavoliūnienė , Regina Jonkaitienė , Laura Urbonaitė
• Języki publikacji: EN

Abstrakty

EN

Streptococcus pneumoniae is an uncommon cause of infective endocarditis; it often requires prolonged antibacterial treatment and involves a high mortality rate. We report a rare case of pneumococcal endocarditis manifesting with unusual complications - meningitis and endophthalmitis. Streptococcus pneumoniae species grew from the cerebrospinal fluid. The diagnosis of native aortic valve infective endocarditis was confirmed after some delay by transesophageal echocardiography. The patient’s eye was lost because of infective complications, but his life was saved following an aggressive antibacterial therapy in combination with an immediate aortic valve replacement.

Słowa kluczowe

EN

Streptococcus pneumoniae; Endocarditis; Meningitis; Endophthalmitis

• Czasopismo: Open Medicine
• Rocznik: 2013
• Tom: 8
• Numer: 6
• Strony: 795-798

Daty

wydano

2013-12-01

online

2013-12-06

Twórcy

autor

Aušra Kavoliūnienė

• Department of Cardiology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania

autor

Regina Jonkaitienė

• Department of Cardiology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania

autor

Laura Urbonaitė

• Medical Academy, Lithuanian University of Health Sciences Kaunas Clinics, Eiveniu str. 2, LT-50009, Kaunas, Lithuania,

Bibliografia

• [1] Mylonakis E., Calderwood S.B., Infective endocarditis in adults, N. Engl. J. Med., 2001, 345, 1318–1330 http://dx.doi.org/10.1056/NEJMra010082[Crossref]
• [2] Rueda A.M., Serpa J.A., Matloobi M., Mushtaq M., Musher D.M., The spectrum of invasive pneumococcal disease at an adult tertiary care hospital in the early 21st century, Medicine (Baltimore), 2010, 89, 331–336 http://dx.doi.org/10.1097/MD.0b013e3181f2b824[Crossref]
• [3] Karchmer A.W., Infective endocarditis, In: Bonow R.O., Mann D.L., Zipes D.P., Libby P. (Eds.), Braunwald’s heart disease: a textbook of cardiovascular medicine, 9th ed., Pa: Saunders Elsevier, Philadelphia, 2012
• [4] Lindberg J., Schønheyder H.C., Møller J.K., Prag J., Incidence of pneumococcal endocarditis: a regional health register-based study in Denmark 1981–1996, Scand. J. Infect. Dis., 2005, 37, 417–421 http://dx.doi.org/10.1080/00365540510035292[Crossref]
• [5] Habib G., Hoen B., Tornos P., Thuny F., Prendergast B., Vilacosta I. et al., ESC Committee for Practice Guidelines. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer, Eur. Heart. J., 2009, 30, 2369–2413 http://dx.doi.org/10.1093/eurheartj/ehp285[Crossref]
• [6] Sexton D.J., Invasive pneumococcal (Streptococcus pneumoniae) infections and bacteremia, available in the UpToDate database (http://www.uptodate.com/home)
• [7] Lee S., Um T., Joe S.G., Hwang J.U., Kim J.G., Yoon Y.H. et al., Changes in the clinical features and prognostic factors of endogenous endophthalmitis: fifteen years of clinical experience in Korea, Retina, 2012, 32, 977–984 http://dx.doi.org/10.1097/IAE.0b013e318228e312[WoS][Crossref]
• [8] Christensen J.S., Jensen T.G., Kolmos H.J., Pedersen C., Lassen A., Bacteremia with Streptococcus pneumoniae: sepsis and other risk factors for 30-day mortality - a hospital-based cohort study, Eur. J. Clin. Microbiol. Infect. Dis., 2012, 31, 2719–2725 http://dx.doi.org/10.1007/s10096-012-1619-5[WoS][Crossref]
• [9] Wilbring M., Tugtekin S.M., Matschke K., Kappert U., Austrian syndrome in the context of a fulminant pneumococcal native valve endocarditis, Braz. J. Infect. Dis., 2012, 16, 486–488 http://dx.doi.org/10.1016/j.bjid.2012.08.003[Crossref][WoS]
• [10] Sonneville R., Mirabel M., Hajage D., Tubach F., Vignon P., Perez P. et al., on behalf of ENDOcardite en REAnimation Study Group, Neurologic complications and outcomes of infective endocarditis in critically ill patients: the ENDOcardite en REAnimation prospective multicenter study, Crit. Care Med., 2011, 39, 1474–1481 http://dx.doi.org/10.1097/CCM.0b013e3182120b41[Crossref][WoS]
• [11] Baddour L.M., Wilson W.R., Bayer A.S., Fowler V.G. Jr., Bolger A.F., Levison M.E., Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America, Circulation, 2005, 111, 394–434 http://dx.doi.org/10.1161/CIRCULATIONAHA.105.165564[Crossref]
• [12] Fayad G., Vincentelli A., Leroy G., Devos P., Amr G., Prat A. et al., Impact of antimicrobial therapy on prognosis of patients requiring valve surgery during active infective endocarditis, J. Thorac. Cardiovasc. Surg., 2012, http://www.jtcvsonline.org/article/S0022-5223(12)01285-8/fulltext [WoS]
• [13] Kang D.H., Kim Y.J., Kim S.H., Early Surgery versus Conventional Treatment for Infective Endocarditis, N. Engl. J. Med., 2012, 366, 2466–2473 http://dx.doi.org/10.1056/NEJMoa1112843[Crossref]

Identyfikatory

DOI

10.2478/s11536-013-0223-0